Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases
- PMID: 16285725
- DOI: 10.1021/bi0513610
Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases
Abstract
A series of L-nitroarginine-based dipeptide inhibitors are highly selective for neuronal nitric oxide synthase (nNOS) over the endothelial isoform (eNOS). Crystal structures of these dipeptides bound to both isoforms revealed two different conformations, curled in nNOS and extended in eNOS, corresponding to higher and lower binding affinity to the two isoforms, respectively. In previous studies we found that the primary reason for selectivity is that Asp597 in nNOS, which is Asn368 in eNOS, provides greater electrostatic stabilization in the inhibitor complex. While this is the case for smaller dipeptide inhibitors, electrostatic stabilization may no longer be the sole determinant for isoform selectivity with bulkier dipeptide inhibitors. Another residue farther away from the active site, Met336 in nNOS (Val106 in eNOS), is in contact with bulkier dipeptide inhibitors. Double mutants were made to exchange the D597/M336 pair in nNOS with N368/V106 in eNOS. Here we report crystal structures and inhibition constants for bulkier dipeptide inhibitors bound to nNOS and eNOS that illustrate the important role played by residues near the entry to the active site in isoform selective inhibition.
Similar articles
-
Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.Acc Chem Res. 2009 Mar 17;42(3):439-51. doi: 10.1021/ar800201v. Acc Chem Res. 2009. PMID: 19154146 Free PMC article. Review.
-
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.Nat Struct Mol Biol. 2004 Jan;11(1):54-9. doi: 10.1038/nsmb704. Epub 2003 Dec 29. Nat Struct Mol Biol. 2004. PMID: 14718923
-
Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.Biochemistry. 2004 May 11;43(18):5181-7. doi: 10.1021/bi0361867. Biochemistry. 2004. PMID: 15122883
-
Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters.J Med Chem. 1997 Aug 29;40(18):2813-7. doi: 10.1021/jm970200u. J Med Chem. 1997. PMID: 9288162
-
Medicinal Chemistry Insights in Neuronal Nitric Oxide Synthase Inhibitors Containing Nitrogen Heterocyclic Compounds: A Mini Review.Chem Biodivers. 2025 Mar;22(3):e202402637. doi: 10.1002/cbdv.202402637. Epub 2024 Nov 13. Chem Biodivers. 2025. PMID: 39436922 Review.
Cited by
-
Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model.J Am Chem Soc. 2010 Apr 21;132(15):5437-42. doi: 10.1021/ja910228a. J Am Chem Soc. 2010. PMID: 20337441 Free PMC article.
-
Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.Acc Chem Res. 2009 Mar 17;42(3):439-51. doi: 10.1021/ar800201v. Acc Chem Res. 2009. PMID: 19154146 Free PMC article. Review.
-
Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.Bioorg Med Chem. 2007 Sep 15;15(18):6096-108. doi: 10.1016/j.bmc.2007.06.038. Epub 2007 Jun 23. Bioorg Med Chem. 2007. PMID: 17614291 Free PMC article.
-
Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.Ann Neurol. 2009 Feb;65(2):209-17. doi: 10.1002/ana.21555. Ann Neurol. 2009. PMID: 19235180 Free PMC article.
-
Nitric oxide synthase and structure-based inhibitor design.Nitric Oxide. 2017 Feb 28;63:68-77. doi: 10.1016/j.niox.2016.11.004. Epub 2016 Nov 23. Nitric Oxide. 2017. PMID: 27890696 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources